Search Results - "Toppmeyer, D"

Understanding Cancer Genetic Risk Assessment Intentions in a Tailored Risk Communication Intervention Randomized Controlled Trial.

Authors: LeCompte, C. G. McDougall, J. Walters, S. T. et al.

Source: Cancer Epidemiology, Biomarkers & Prevention. 7/1/2022, Vol. 31 Issue 7, p1513-1514.

Pembrolizumab monotherapy for previously untreated, PD-L1-positive, metastatic triple-negative breast cancer: cohort B of the phase II KEYNOTE-086 study.

Authors: Adams, S Loi, S Toppmeyer, D et al.

Source: Annals of Oncology. Mar2019, Vol. 30 Issue 3, p405-411. 7p. 3 Charts, 1 Graph.

Pre-Operative Boost Results in Low Rates of Re-Excision and Reduced Time from Initial Diagnosis to Completion of Local-Regional Treatment in Breast Cancer Patients.

Authors: Chakraborty, M.A. Sherwani, Z. Yehia, Z. Abou et al.

Source: International Journal of Radiation Oncology, Biology, Physics. 2024 Supplement, Vol. 120 Issue 2, pS201-S202. 2p.

Clinical Outcomes in Breast Cancer Patients with Underlying Germline PALB2 Mutations Treated with Radiation.

Authors: Shalaby, A. Jan, I. Ohri, N. et al.

Source: International Journal of Radiation Oncology, Biology, Physics. 2024 Supplement, Vol. 120 Issue 2, pe331-e332. 2p.

APBI (Accelerated Partial-Breast Irradiation) Versus WBI (Whole-Breast Irradiation) Delivered with the Same Dose Fractionation: A Propensity Score Matched Analysis of Two Prospective Studied Cohorts.

Authors: Yehia, Z. Abou Gupta, A. Toppmeyer, D. et al.

Source: International Journal of Radiation Oncology, Biology, Physics. Sep2019 Supplement, Vol. 105, pE14-E14. 1p.

Subjects: Propensity score matching, Irradiation

Pembrolizumab monotherapy for previously treated metastatic triple-negative breast cancer: cohort A of the phase II KEYNOTE-086 study.

Authors: Adams, S Schmid, P Rugo, H S et al.

Source: Annals of Oncology. Mar2019, Vol. 30 Issue 3, p397-404. 8p. 3 Charts, 1 Graph.

Breast cancer in young women (YBC): prevalence of BRCA1/2 mutations and risk of secondary malignancies across diverse racial groups.

Authors: Haffty, B. G. Choi, D. H. Goyal, S. et al.

Source: Annals of Oncology. Oct2009, Vol. 20 Issue 10, p1653-1659. 7p. 5 Charts, 2 Graphs.

Clinical Toxicity in Hypofractionated and Conventionally Fractionated Radiation in Breast Cancer Patients with Germline ATM Mutations.

Authors: Jan, I. Yehia, Z.A. Ghaddar, B. et al.

Source: International Journal of Radiation Oncology, Biology, Physics. 2022 Supplement, Vol. 114 Issue 3, pe31-e31. 1p.

Utilization of Hypofractionated Whole-Breast Radiotherapy with Concurrent Anti-Human Epidermal Growth Factor Receptor 2 (HER2) Therapy.

Authors: Sayan, M. Vergalasova, I. Jhawar, S.R. et al.

Source: International Journal of Radiation Oncology, Biology, Physics. Sep2019 Supplement, Vol. 105, pE31-E32. 2p.

Reconstruction Outcomes in a Multi-Institution Prospective Phase II Hypofractionated Post-Mastectomy Radiation Therapy Trial.

Authors: Yehia, Z. Abou Poppe, M.M. Baker, C.B. et al.

Source: International Journal of Radiation Oncology, Biology, Physics. 2020 Supplement, Vol. 108 Issue 3, pS11-S11. 1p.

Five-Year Results of a Prospective Phase 2 Trial Evaluating Three-Week Hypofractionated Whole Breast Radiation Therapy with Boost.

Authors: Gupta, A. Khan, A.J. Wang, S.J. et al.

Source: International Journal of Radiation Oncology, Biology, Physics. Nov2018 Supplement, Vol. 102, pS79-S79. 1p.

Accelerated, Hypofractionated Whole-Breast Radiation Therapy in Women With Breast Cancer: A Phase 2 Trial.

Authors: Ahlawat, S. Khan, A.J. Goyal, S. et al.

Source: International Journal of Radiation Oncology, Biology, Physics. Sep2014 Supplement, Vol. 90 Issue 1, pS269-S270. 1p.

Development and feasibility testing of a conversational chatbot supporting genetic education and testing for hereditary cancer.

Authors: Tundealao S Heidt E Grumet S et al.

Source: Journal of community genetics [J Community Genet] 2026 Jun 22; Vol. 17 (3). Date of Electronic Publication: 2026 Jun 22.

Publication Type: Journal Article

Journal Info: Publisher: Springer Country of Publication: Germany NLM ID: 101551501 Publication Model: Electronic Cited Medium: Print ISSN: 1868-310X (Print) Linking ISSN: 1868310X NLM ISO Abbreviation: J Community Genet Subsets: PubMed not MEDLINE

Expanding access to cancer genetic care for cancer survivors: Rationale and design for a randomized controlled trial of a chatbot-based genetic education and testing.

Authors: An J Huq M Speiser E et al.

Source: Contemporary clinical trials [Contemp Clin Trials] 2026 Mar; Vol. 162, pp. 108217. Date of Electronic Publication: 2026 Jan 17.

Publication Type: Journal Article; Clinical Trial Protocol

Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 101242342 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1559-2030 (Electronic) Linking ISSN: 15517144 NLM ISO Abbreviation: Contemp Clin Trials Subsets: MEDLINE

Reply to: "Preoperative Radiation Boost in Early Stage Breast Cancer: Effect on Re-excision and Complication Rates," by Sanli, Deniz et al.

Authors: Chakraborty M Sherwani Z Narra LR et al.

Source: Annals of surgical oncology [Ann Surg Oncol] 2025 Dec; Vol. 32 (13), pp. 9912-9913. Date of Electronic Publication: 2025 Oct 08.

Publication Type: Letter

Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 9420840 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-4681 (Electronic) Linking ISSN: 10689265 NLM ISO Abbreviation: Ann Surg Oncol Subsets: MEDLINE; In Process

Ovarian Suppression: Early Menopause, Late Effects.

Authors: Goldberg C Greenberg MR Noveihed A et al.

Source: Current oncology reports [Curr Oncol Rep] 2024 May; Vol. 26 (5), pp. 427-438. Date of Electronic Publication: 2024 Jan 02.

Publication Type: Journal Article; Review

Journal Info: Publisher: Current Science Country of Publication: United States NLM ID: 100888967 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-6269 (Electronic) Linking ISSN: 15233790 NLM ISO Abbreviation: Curr Oncol Rep Subsets: MEDLINE

Randomized trial promoting cancer genetic risk assessment when genetic counseling cost removed: 1-year follow-up.

Authors: An J McDougall J Lin Y et al.

Source: JNCI cancer spectrum [JNCI Cancer Spectr] 2024 Feb 29; Vol. 8 (2).

Publication Type: Randomized Controlled Trial; Journal Article

Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 101721827 Publication Model: Print Cited Medium: Internet ISSN: 2515-5091 (Electronic) Linking ISSN: 25155091 NLM ISO Abbreviation: JNCI Cancer Spectr Subsets: MEDLINE

HLA inherence as a potential parameter in checkpoint inhibitor-associated autoimmune adverse event assessment.

Authors: Gandarillas S Newland ES Toppmeyer D et al.

Source: Frontiers in medicine [Front Med (Lausanne)] 2024 Jan 08; Vol. 10, pp. 1288844. Date of Electronic Publication: 2024 Jan 08 (Print Publication: 2023).

Publication Type: Journal Article

Journal Info: Publisher: Frontiers Media S.A Country of Publication: Switzerland NLM ID: 101648047 Publication Model: eCollection Cited Medium: Print ISSN: 2296-858X (Print) Linking ISSN: 2296858X NLM ISO Abbreviation: Front Med (Lausanne) Subsets: PubMed not MEDLINE

Impact of Preoperative Radiation Boost on Oncotype DX^® Result in a Phase II Clinical Trial.

Authors: Eladoumikdachi F Chakraborty MA Ohri N et al.

Source: Annals of surgical oncology [Ann Surg Oncol] 2025 Jul 09. Date of Electronic Publication: 2025 Jul 09.

Publication Type: Letter

Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 9420840 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-4681 (Electronic) Linking ISSN: 10689265 NLM ISO Abbreviation: Ann Surg Oncol Subsets: MEDLINE

Identifying Mediators of Intervention Effects Within a Randomized Controlled Trial to Motivate Cancer Genetic Risk Assessment Among Breast and Ovarian Cancer Survivors.

Authors: An J Lu SE McDougall J et al.

Source: Annals of behavioral medicine : a publication of the Society of Behavioral Medicine [Ann Behav Med] 2023 Oct 16; Vol. 57 (11), pp. 965-977.

Publication Type: Randomized Controlled Trial; Journal Article

Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 8510246 Publication Model: Print Cited Medium: Internet ISSN: 1532-4796 (Electronic) Linking ISSN: 08836612 NLM ISO Abbreviation: Ann Behav Med Subsets: MEDLINE